TENOFOVIR DIPHOSPHATE TO PREDICT FUTURE VIRAEMIA IN POSTPARTUM WOMEN LIVING WITH HIV
There are few data on how tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) predicts future viral load (VL) in people living with HIV on antiretroviral therapy (ART). We conducted a nested case-control study within a trial of differentiated care for postpartum ART (NCT03200054). Women were >18 years, started ART (TDF+3TC+EFV) in pregnancy and were…